# Anika Therapeutics, Inc.: Form 10-K/A for the period ended Dec 31, 2023

- Company: [Anika Therapeutics, Inc.](/companies/anik.md) (CIK 898437)
- Form: 10-K/A
- Filed: 2024-04-26
- Accepted by EDGAR: Apr 26, 2024, 08:48 ET
- Period: 2023-12-31
- Accession: 0001171843-24-002274
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/898437/000117184324002274/anik20231231_10ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/898437/000117184324002274/

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/898437/000117184324002274/anik20231231_10ka.htm

Filed Apr 26, 2024.
Source: SEC EDGAR, the filing index for accession 0001171843-24-002274. Last ingested by Listed: Nov 6, 2026, 15:05 ET. No prices; not investment advice.